amgen glp 1 agonist Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist What is the pipeline for

Description

Conclusion arGLP-1 are effective and safe for managing IWL or WR after BS, leading to significant weight loss, comorbidity improvement, and sustained %TWL

The identified literature was narratively synthesized without formal study selection protocols, risk-of-bias assessment, or quantitative meta-analysis

310 (2), H153H173

de Leeuw, C

Gallbladder problems are uncommon but important to monitor

With findings from numerous trials on glycemic, body weight and CV outcomes scheduled to be presented over the next 4 years, many more treatment options could be become available for providers in the near future, Davies said